What Happened? A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the ...

Amgen Inc. (NASDAQ:AMGN) is one of the high-margin pharma stocks to buy now. HSBC has lowered its price target on Amgen Inc.

The expiration of the enhanced ACA premium subsidies at the end of this year is prompting many insurers to hike rates by an ...

Despite former President Donald Trump’s threat of a 200% tariff on imported drugs during a cabinet meeting, pharmaceutical investors have shown surprisingly positive sentiment this week. Despite ...

Bessent's victory lap on tariff revenues was premature. And so are hopes that the trade war won't damage commerce and the U.S. economy.

CIO & PM of leading sector ETF explains what has been impacting leading names and why he still sees strong long-term ...

The Treasurer says he is evaluating the impact of US drug tariffs on the Pharmaceutical Benefits Scheme but says subsidies ...

Exporters from engineering, plastics and pharmaceuticals said delayed tariff decisions from Washington had stalled expansion plans, pushed back new US orders and clouded short-term growth.

The opening salvo of second-quarter earnings calls this week came against President Donald Trump’s renewed calls for a tariff ...

President Trump has threatened to levy tariffs of up to 200% on pharmaceutical imports. Lilly's margins could be negatively ...

The pharmaceutical sector continues to stand out as a resilient and highly profitable corner of the market, even amid global ...

Getinge's quarterly earnings beat market expectations on Friday, driven by organic sales growth across its business areas and regions, as the medical equipment maker seeks ways beyond pricing to ...